GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Gross Profit

Lombard Medical Technologies (LSE:LMT) Gross Profit : £1.40 Mil (TTM As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Gross Profit?

Lombard Medical Technologies's gross profit for the six months ended in Dec. 2012 was £1.40 Mil. Lombard Medical Technologies's gross profit for the trailing twelve months (TTM) ended in Dec. 2012 was £1.40 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Lombard Medical Technologies's gross profit for the six months ended in Dec. 2012 was £1.40 Mil. Lombard Medical Technologies's Revenue for the six months ended in Dec. 2012 was £3.89 Mil. Therefore, Lombard Medical Technologies's Gross Margin % for the quarter that ended in Dec. 2012 was 35.99%.

Lombard Medical Technologies had a gross margin of 35.99% for the quarter that ended in Dec. 2012 => Competition eroding margins

During the past 10 years, the highest Gross Margin % of Lombard Medical Technologies was 63.59%. The lowest was 20.73%. And the median was 42.32%.

Warning Sign:

Lombard Medical Technologies PLC gross margin has been in long term decline. The average rate of decline per year is -2.7%.


Lombard Medical Technologies Gross Profit Historical Data

The historical data trend for Lombard Medical Technologies's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Gross Profit Chart

Lombard Medical Technologies Annual Data
Trend Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.77 0.99 1.37 1.97 1.40

Lombard Medical Technologies Semi-Annual Data
Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.77 0.99 1.37 1.97 1.40

Competitive Comparison of Lombard Medical Technologies's Gross Profit

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lombard Medical Technologies's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's Gross Profit distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's Gross Profit falls into.



Lombard Medical Technologies Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Lombard Medical Technologies's Gross Profit for the fiscal year that ended in Dec. 2012 is calculated as

Gross Profit (A: Dec. 2012 )=Revenue - Cost of Goods Sold
=3.89 - 2.49
=1.40

Lombard Medical Technologies's Gross Profit for the quarter that ended in Dec. 2012 is calculated as

Gross Profit (Q: Dec. 2012 )=Revenue - Cost of Goods Sold
=3.89 - 2.49
=1.40

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Gross Profit for the trailing twelve months (TTM) ended in Dec. 2012 was £1.40 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Lombard Medical Technologies's Gross Margin % for the quarter that ended in Dec. 2012 is calculated as

Gross Margin % (Q: Dec. 2012 )=Gross Profit (Q: Dec. 2012 ) / Revenue (Q: Dec. 2012 )
=(Revenue - Cost of Goods Sold) / Revenue
=1.40 / 3.89
=35.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Lombard Medical Technologies  (LSE:LMT) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Lombard Medical Technologies had a gross margin of 35.99% for the quarter that ended in Dec. 2012 => Competition eroding margins


Lombard Medical Technologies Gross Profit Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Lombard Medical Technologies (LSE:LMT) Business Description

Traded in Other Exchanges
N/A
Address
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.

Lombard Medical Technologies (LSE:LMT) Headlines